Últimos Artículos de Metabolism Clinical and Experimental
- Editorial Board
- Burden of metabolic diseases, 1990-2023, with forecasts to 2030 for the Asia-Pacific region
- ADH1C as a robust prognostic biomarker in hepatocellular carcinoma: Evidence from a multi-cohort meta-analysis
- Hyperinsulinemia drives glomerular podocyte injury and albuminuria via a self-perpetuating GSK3β–IRS1 insulin desensitization circuit
- Sex differences in cardiovascular-kidney-metabolic syndrome and new onset cardiovascular outcomes
- Association of daytime circadian-aligned activity with glycemic control in type 2 diabetes: Insights from continuous glucose monitoring and wearable data
- From mechanism to clinic: A call for actionable strategies to optimize finerenone and SGLT2i complementary therapy in T2DM-related CKD
- Targeting Gβγ subunits in hypothalamic AgRP neurons to treat obesity
- Corrigendum to “Current and investigational medications for the treatment of sarcopenia” [Metabolism 2023;149:155597]
- Folic acid mitigation of alcohol-induced sarcopenia via gut-muscle axis modulation
- The early metabolic cardiac targets of empagliflozin during the development of heart failure, independent of SGLT2 inhibition
- Mini-review. Vitamin D for the prevention of type 2 diabetes: Evidence and implications
- Editorial Board
- The multifaceted role of GLP-1 in metabolic disorders, chronic inflammation, and aging: Mechanisms and therapeutic potential
- Serum Response Factor (SRF) promotes actin cytoskeletal organization in adipocytes to support adaptive hypertrophic expansion and tissue remodeling during obesity in mice
- A biological-systems-based analysis using proteomic and metabolic network inference reveals mechanistic insights into hepatic steatosis
- PFKFB3 nuclear translocation improves diabetic retinopathy by attenuating endothelial cell senescence through inhibition of USP7-p53 axis
- Enduring improvements in hepatic insulin sensitivity predict sustained remission of prediabetes during a 3-year lifestyle intervention: results from the PREVIEW multinational diabetes prevention trial
- Rising burden of MASLD and CKM syndrome in Asia: A decade of trends and future projections
- From liver to vasculature: An integrated view of cardiovascular risk in hepatic steatosis